PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Настройки учетной записи
    • Выйти
    • Войти
    • Зарегистрироваться

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20180816 150843
20180131 165519
20180131 160131
20180814 160711
20170730 175202
IMG-20170806-WA0035
  • Drug Shortages
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-24 By FDA
  • FDA approves first treatment for activated phosphoinositide 3-kinase delta syndrome
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Drug Safety and Risk Management Advisory Committee Roster
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Blood Products Advisory Committee April 26, 2023 Meeting Announcement - 04/26/2023
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-24 By FDA
  • GDUFA Implementation Quarterly Meetings between FDA and Industry
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Over-the-Counter (OTC) Drug Review | OTC Monograph Reform in the CARES Act
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Spondylitis, Ankylosing;Arthritis, Rheumatoid;Uveitis;Colitis, Ulcerative;Psoriasis;Arthritis, Psoriatic;Crohn Disease;Hidradenitis Suppurativa;Arthritis, Date of authorisation: 24/08/2017, Revision: 20, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-03-24
  • Drug Compounding and Drug Shortages
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Over-The-Counter Monograph Drug User Fee Program (OMUFA)
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Dermatologic and Ophthalmic Drugs Advisory Committee Roster
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
  • Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products - 04/27/2023
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-23 By FDA
  • FDA CDER & JHU CERSI Workshop | Addressing Challenges in the Design and Analysis of Rare Disease Clinical Trials: Considerations and Tools - 05/02/2023
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-23 By FDA
  • Immune Globulin Hypersensitivity Reactions: Root Causes and Mitigation; Public Workshop - 03/30/2023
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-23 By FDA
Предыдущие записи
Тема: Scaffold от Danny Cooper.